Objective: To evaluate the effectiveness of intravenous immunoglobulin (IVIG) in patients presenting with recurrent miscarriage and abnormally elevated natural killer (NK) cells.
Study Design: This retrospective patient controlled evidence level II-2 pilot study was conducted at Cohen Center, P.A.
Objective: To review the obstetric outcome of 240 diabetic pregnancies maintained on basal glargine insulin.
Study Design: This is a retrospective review of the medical data from 240 pregnant diabetics who received glargine as a basal insulin. Perinatal outcome was abstracted from August 29, 2001, to December 31, 2007.